Report Feature
The future of the global medical biomimetic market looks promising with opportunities in plastic surgery, wound healing, tissue engineering, and drug delivery applications. The global medical biomimetic market is expected to grow with a CAGR of 5%-7% from 2020 to 2025. The major drivers for this market are increasing research and development activities related to medical biomimetics, rising geriatric population, and the growing tissue engineering market.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global medical biomimetic market report, please download the report brochure.
In this market, cardiovascular is the largest product of medical biometric, whereas drug delivery is the largest application. Growth in various segments of the medical biometric market are given below:
The study includes trends and forecast for the global medical biomimetic market by product, application, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Cardiovascular
-
Orthopedics
- Prostheses
- Exoskeleton
- Ophthalmology
- Dental
- Others
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Plastic Surgery
- Wound Healing
- Tissue Engineering
- Drug Delivery
- Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the medical biomimetic companies profiled in this report include Abbott, Avinent Implant System, BioHorizons Implant Systems, BioTomo, Skyler Brand Ventures, Hstar Technologies, Blatchford, SynTouch, Veryan Medical, and Applied Biomimetic.
Lucintel forecasts that cardiovascular will remain the largest product segment over the forecast period due to rising mortality rate due to cardiac disorders and new product development to cure cardiac disorder.
Within this market, drug delivery will remain the largest application segment over the forecast period due to advancements in nanotechnology and rising performance of vaccines as well as accurate drug delivery of nanocarriers through biomimetic devices.
North America will remain the largest region over the forecast period due to rising geriatric population, increasing prevalence of chronic diseases, growing adoption of novel technology, and surge in research and development activities related to medical biomimetics in the region.
|
Features of the Global Medical Biomimetic Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global medical biomimetic market by product (cardiovascular, orthopedics (prostheses and exoskeleton), ophthalmology, dental, and others), application (plastic surgery, wound healing, tissue engineering, drug delivery, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global medical biomimetic market? Q.5 What are the business risks and threats to the global medical biomimetic market? Q.6 What are the emerging trends in this medical biomimetic market and the reasons behind them? Q.7 What are some changing demands of customers in this medical biomimetic market? Q.8 What are the new developments in this medical biomimetic market? Which companies are leading these developments? Q.9 Who are the major players in this medical biomimetic market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this medical biomimetic market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global medical biomimetic market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Cardiovascular, Orthopedics (Prostheses and Exoskeleton), Ophthalmology, Dental, and Others), and Application (Plastic Surgery, Wound Healing, Tissue Engineering, Drug Delivery, and Others) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
4.1 Global Medical Biomimetic Market by Region
4.2.1 Market by Product: Cardiovascular, Orthopedics (Prostheses and Exoskeleton), Opthalmology, Dental, and Others
4.2.2 Market by Application: Plastic Surgery, Wound Healing, Tissue Engineering, Drug Delivery, and Others
4.2.3 The United States Medical Biomimetic Market
4.2.4 The Canadian Medical Biomimetic Market
4.2.5 The Mexican Medical Biomimetic Market
4.3.1 Market by Product: Cardiovascular, Orthopedics (Prostheses and Exoskeleton), Opthalmology, Dental, and Others
4.3.2 Market by Application: Plastic Surgery, Wound Healing, Tissue Engineering, Drug Delivery, and Others
4.3.3 The Medical Biomimetic Market of United Kingdom
4.3.4 The German Medical Biomimetic Market
4.3.5 The French Medical Biomimetic Market
4.4.1 Market by Product: Cardiovascular, Orthopedics (Prostheses and Exoskeleton), Opthalmology, Dental, and Others
4.4.2 Market by Application: Plastic Surgery, Wound Healing, Tissue Engineering, Drug Delivery, and Others
4.4.3 The Chinese Medical Biomimetic Market
4.4.4 The Indian Medical Biomimetic Market
4.4.5 The Japanese Medical Biomimetic Market
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
